World's Best Scientists 2026 revealed!
Kazuhiko Takehara

Kazuhiko Takehara

D-Index & Metrics

Immunology

D-Index
88
Citations
22655
World Ranking
1186
National Ranking
44

Medicine

D-Index
89
Citations
23050
World Ranking
12859
National Ranking
376

Kazuhiko Takehara publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kazuhiko Takehara sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 364 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kazuhiko Takehara D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kazuhiko Takehara sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kazuhiko Takehara is affiliated with Kanazawa University in Japan and focuses their research primarily in the field of Medicine. Their work spans multiple subfields, including Pathology and Forensic Medicine, Immunology, Dermatology, Epidemiology, and Rheumatology.

The scientist's research covers a range of topics, with a particular emphasis on systemic sclerosis and related diseases. Other main topics of their research include mast cells and histamine, inflammatory myopathies and dermatomyositis, dermatologic treatments and research, celiac disease research and management, interstitial lung diseases and idiopathic pulmonary fibrosis, and eosinophilic disorders and syndromes.

Frequent venues publishing their research include:

  • Modern Rheumatology
  • European Journal of Dermatology
  • The Journal of Dermatology
  • Journal of Dermatological Science
  • The Lancet Respiratory Medicine

Takehara has collaborated extensively with several coauthors, including:

  • Takashi Matsushita
  • Yasuhito Hamaguchi
  • Masataka Kuwana
  • Osamu Ishikawa
  • Minoru Hasegawa

Among recent papers associated with Takehara's research are:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial (2020, The Lancet Respiratory Medicine)
  • Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies (2020, Clinical Rheumatology)
  • Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial (2020, Modern Rheumatology)
  • Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis (2020, Lara D. Veeken)
  • GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region (2024, Nature Communications)

Best Publications

  • Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model.

    Toshifumi Mori;Shigeru Kawara;Mikio Shinozaki;Nobukazu Hayashi

  • Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders

    Atsuyuki Igarashi;Kiyoko Nashiro;Kanako Kikuchi;Shinichi Sato

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity

    Shinichi Sato;Minoru Hasegawa;Manabu Fujimoto;Thomas F. Tedder

  • Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

    Yasuhito Hamaguchi;Manabu Fujimoto;Takashi Matsushita;Kenzo Kaji

  • Smad6 Is a Smad1/5-induced Smad Inhibitor CHARACTERIZATION OF BONE MORPHOGENETIC PROTEIN-RESPONSIVE ELEMENT IN THE MOUSE Smad6 PROMOTER

    Wataru Ishida;Wataru Ishida;Toshiaki Hamamoto;Kiyoshi Kusanagi;Ken Yagi

  • Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

    Yasuhito Hamaguchi;Masataka Kuwana;Kana Hoshino;Minoru Hasegawa

  • Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.

    Shinichi Sato;Minoru Hasegawa;Kazuhiko Takehara

  • Guidelines for management of atopic dermatitis

    Hidehisa Saeki;Masutaka Furue;Fukumi Furukawa;Michihiro Hide

  • Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

    Shinichi Sato;Tetsuya Nagaoka;Minoru Hasegawa;Takuya Tamatani

  • Elevated serum BAFF levels in patients with systemic sclerosis: Enhanced BAFF signaling in systemic sclerosis B lymphocytes

    Takashi Matsushita;Minoru Hasegawa;Koichi Yanaba;Masanari Kodera

  • CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.

    Eriko Saito;Manabu Fujimoto;Minoru Hasegawa;Kazuhiro Komura

  • Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.

    Manabu Fujimoto;Yasuhito Hamaguchi;Kenzo Kaji;Takashi Matsushita

  • Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy

    Yuki Ichimura;Takashi Matsushita;Yasuhito Hamaguchi;Kenzo Kaji

  • Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.

    Nahoko Komatsu;Minoru Takata;Norio Otsuki;Rie Ohka

  • Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.

    Yuka Shimada;Kazuhiko Takehara;Shinichi Sato

  • Delayed Wound Healing in the Absence of Intercellular Adhesion Molecule-1 or L-Selectin Expression

    Tetsuya Nagaoka;Yuko Kaburagi;Yasuhito Hamaguchi;Minoru Hasegawa

  • B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.

    Minoru Hasegawa;Yasuhito Hamaguchi;Koichi Yanaba;Jean-David Bouaziz

  • Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients

    Nahoko Komatsu;Kiyofumi Saijoh;Cynthia Kuk;Amber C. Liu

  • Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

    Kayo Arikawa;Noriko Takuwa;Hironori Yamaguchi;Naotoshi Sugimoto

Frequent Co-Authors

Minoru Hasegawa
Minoru Hasegawa University of Fukui
Shinichi Sato
Shinichi Sato University of Tokyo
Manabu Fujimoto
Manabu Fujimoto Osaka University
Hironobu Ihn
Hironobu Ihn Kumamoto University
Koichi Yanaba
Koichi Yanaba Jikei University School of Medicine
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Thomas F. Tedder
Thomas F. Tedder Duke University
Yoshihide Asano
Yoshihide Asano University of Tokyo
Eleftherios P. Diamandis
Eleftherios P. Diamandis Mount Sinai Hospital
Osamu Ishikawa
Osamu Ishikawa Gunma University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing a related nursing degree can open many doors in healthcare and research. Many students explore pathways such as Family Nurse Practitioner (FNP) roles, with options to advance via an accelerated FNP program. These programs are designed to fast-track nursing students into advanced practice roles, where immunology knowledge is often applied.

Nurses aiming to specialize further might consider transitioning from an FNP to a more focused role. Guidance on how to make this shift is outlined in resources like fnp to acute care np pathways, which emphasize acute care skills important in immunology-related patient populations.

For those without prior nursing experience, enrolling in an online BSN programs for non nurses offers a flexible way to enter the field. These programs cover foundational nursing science and often include immunology coursework.

Additionally, accelerated BSN programs for non nurses provide another route for rapid entry into nursing careers. These options are essential for aspiring immunology professionals seeking clinical experience combined with academic credentials.

Best Scientists Citing Kazuhiko Takehara

Trending Scientists

Recently Published Articles